Solitary plasmacytoma of bone (SPB): observations from a randomized phase III trial that evaluated the additional of adjuvant systemic treatment to zoledronic acid (ZA) after definitive radiation (alliance A061402)
Solitary plasmacytoma of bone (SPB) is a localized tumor in the bone comprised of clonal plasma cells in the absence of other diagnostic features of multiple myeloma (MM), though patients may present with <10% clonal plasma cells in the bone marrow [ 1 ]. Most patients with SPB eventually develop overt MM, and numerous factors are associated with a shorter time to progression to active MM, including the presence of high-risk cytogenetics, abnormal serum free light chain ratio, minimal marrow involvement, and high-grade angiogenesis within the plasmacytoma [ 2 , 3 , 4 , 5 ].
Authors
- Saad Z. Usmani (ORCID: https://orcid.org/0000-0002-5484-8731)
- Destin Carlisle
- Benjamin Marshall Parsons (ORCID: https://orcid.org/0000-0002-5634-2937)
- Elisabet Esteve Manasanch (ORCID: https://orcid.org/0000-0002-0857-176X)
- Prashant Kapoor (ORCID: https://orcid.org/0000-0002-4342-364X)
- Jose Eugenio Najera
- Ilene A Galinsky (ORCID: https://orcid.org/0000-0002-9158-5061)
- Douglas Weston Sborov (ORCID: https://orcid.org/0000-0003-4268-2698)
- Shira Naomi Dinner (ORCID: https://orcid.org/0000-0002-3635-6741)
- Philip McCarthy (ORCID: https://orcid.org/0000-0002-9577-3879)
- Cesar Rodriguez
- Paul Richardson (ORCID: https://orcid.org/0000-0002-7426-8865)
- Lyle Goldman
- Anuj Mahindra
- James Omel
- Yujia Wen
- Tibor Kovacsovics
- LeAnne Kennedy (ORCID: https://orcid.org/0000-0001-8989-5469)
- Vera Suman (ORCID: https://orcid.org/0000-0002-9640-5189)
Institutions
- Atrium Health Wake Forest Baptist (US)
- Gundersen Health System (US)
- Roswell Park Comprehensive Cancer Center (US)
- Ascension (US)
- Mayo Clinic (US)
- Memorial Sloan Kettering Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Harvard University (US)
- University of Utah (US)
- Alliance for Clinical Trials in Oncology (US)
- Huntsman Cancer Institute (US)
- University of Chicago (US)
- City of Hope (US)
- Ascension Providence Hospital (US)
- Dana-Farber Cancer Institute (US)
- Cancer Centers of Southwest Oklahoma (US)
- Mayo Clinic in Arizona (US)
- Alliance Data (United States) (US)
- Dana-Farber/Harvard Cancer Center (US)
- Scripps MD Anderson Cancer Center (US)
- Tisch Cancer Institute (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Blood Cancer Journal
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1038/s41408-026-01674-w
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Roswell Park Cancer Institute
- Celgene
- Huntsman Cancer Institute
- National Institutes of Health
- University of Texas MD Anderson Cancer Center
- National Cancer Institute